Abbott Receives FDA Approval for New Heart Rhythm Devices Featuring Bluetooth Connectivity and Continuous Remote Monitoring

Originally posted on Abbott.com

Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s next-generation Gallant™ implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) devices. The devices bring new benefits to patients with heart rhythm disorders, including a patient-preferred design without compromising battery longevity and MRI compatibility.  In addition, the new devices offer Bluetooth technology and a new patient smartphone app for improved remote monitoring, allowing for increased patient/physician engagement and streamlined communications.

It is estimated that as many as 6.1 million people in the United States battle cardiac arrhythmias, or abnormal heart rhythms,1 and ICDs are used to help reduce the risks of life-threatening arrhythmias. For patients with heart failure or in situations when the heart’s chambers beat out of sync, CRT-Ds can be used to restore the heart’s natural pattern of beating.

“We are focused on developing and delivering life-changing technologies that impact patient care in a meaningful way,” said Randel Woodgrift, senior vice president, Cardiac Rhythm Management, Abbott. “The Gallant devices are the latest example of how Abbott is driving innovation to meet changing healthcare needs and helping to improve connectivity and engagement between patients and their doctors.”

The new Gallant system pairs with Abbott’s secure myMerlinPulse™, an iOS- and Android™- compatible mobile smartphone app that helps streamline communication between doctors and their patients. The app provides people with access to data, device performance, and transmission history, which helps them take an active role in their healthcare. Through the myMerlinPulse app, physicians can continuously monitor their patients remotely allowing for identification of asymptomatic episodes as well as patient-triggered transmissions, which can lead to earlier intervention and reduce clinical burden.

“The ability for patients to stay connected to their doctors via their implanted device and a smartphone app has the potential to change how healthcare providers and patients communicate with each other,” said Raffaele Corbisiero, M.D., FACC, director of electrophysiology and pacing at Deborah Heart and Lung Center, Browns Mills, N.J. “The FDA’s approval of Abbott’s Gallant devices enables doctors to provide a more collaborative approach to treatment plans and the increased bond between a patient and provider will lead to better outcomes for all.”

The Gallant system received CE Mark for use across Europe earlier this year.

For important safety information, please visit abbott.com.

Latest News

New Jersey, Hair, Discrimination, discriminate

3 Powerful Career Advice Tips for Women in Tech

Working as a woman in tech can have its challenges, especially since the industry is still male-dominated.  Though women make up half (50%) of all U.S. workers in STEM occupations, according to research, however, Black and Hispanic workers continue to be underrepresented in the STEM workforce. Black professionals represent only…

California, board, corporate, directors

California Bill Would Mandate Racial Diversity on Corporate Boards

A recent California bill would mandate diversity in corporate boards for all companies headquartered within the state. The bill would ban all-white corporate boards and comes on the heels of a 2018 law that mandated women hold seats in all corporate boards. This racial diversity bill AB 979 defines “underrepresented…

AT&T Summer Camp

Originally published on ATT.com Welcome to AT&T Summer Camp For kids across the country, summer camp is something to look forward to all year long. It’s a time when they connect with friends, try new things, discover untapped talents and grow as individuals. This summer, we’re reimagining the summer camp…

Southern Company: Low-Income Natural Gas Customers to Receive $1 Million in Energy Assistance Support from Atlanta Gas Light

Originally published on southerncompany.com. Under a mechanism created by the Georgia Public Service Commission last year, Atlanta Gas Light is allocating $1 million for supplemental low-income energy assistance, which will be distributed to qualifying agencies that support customers who need help paying natural gas bills, repairing or replacing natural gas appliances…